Chloroquine for COVID-19: Cutting Through the Hype
Chloroquine for COVID-19: Cutting Through the Hype
President Donald Trump has touted the drug as a treatment but scientists still don’t know for sure that it is effective in patients. A number of clinical trials aim to find out.
Chloroquine for COVID-19: Cutting Through the Hype
Chloroquine for COVID-19: Cutting Through the Hype

President Donald Trump has touted the drug as a treatment but scientists still don’t know for sure that it is effective in patients. A number of clinical trials aim to find out.

President Donald Trump has touted the drug as a treatment but scientists still don’t know for sure that it is effective in patients. A number of clinical trials aim to find out.

antiviral therapy
Remdesivir Works Against Coronaviruses in the Lab
Remdesivir Works Against Coronaviruses in the Lab
Abby Olena | Mar 20, 2020
The antiviral disables RNA replication machinery in MERS and SARS viruses. Can it beat back SARS-CoV-2?
The Latest Drug Trials for Coronavirus
The Latest Drug Trials for Coronavirus
Ashley Yeager | Feb 18, 2020
Under careful watch of the World Health Organization, doctors will test a range of COVID-19 therapies, including HIV and flu antivirals, blood plasma infusions, and traditional Chinese medicines.
Flu and HIV Drugs Show Efficacy Against Coronavirus
Flu and HIV Drugs Show Efficacy Against Coronavirus
Catherine Offord | Feb 3, 2020
Combining the medications improved conditions in patients with severe 2019-nCoV infections, say doctors in Thailand.
Novel DNA-Sensing Pathway Found in Human Cells, Absent in Mice
Novel DNA-Sensing Pathway Found in Human Cells, Absent in Mice
Catherine Offord | Jan 24, 2020
This previously unknown mechanism for spotting foreign genetic material in the cytoplasm launches antiviral defenses even when the well-known immune mediator STING is absent.
Drug-Resistant Flu Can Emerge After Patients Take Antiviral
Drug-Resistant Flu Can Emerge After Patients Take Antiviral
Kerry Grens | Nov 26, 2019
Roughly a quarter of 38 viral samples from people treated with Xofluza had mutations in their genomes that made the pathogens less susceptible to the drug.
Two Experimental Drugs Effective at Treating Ebola
Two Experimental Drugs Effective at Treating Ebola
Catherine Offord | Aug 13, 2019
REGN-EB3 and mAb114 reduced mortality in a clinical trial carried out during the ongoing outbreak in Democratic Republic of Congo.
Many Non-Antibiotic Drugs Affect Gut Bacteria
Many Non-Antibiotic Drugs Affect Gut Bacteria
Catherine Offord | Mar 19, 2018
A new study finds that more than 200 human-targeted, non-antibiotic drugs inhibit the growth of bacterial species that make up part of the human microbiome.
Flu Drug Approved in Japan Claims to Stop Virus in 24 Hours
Flu Drug Approved in Japan Claims to Stop Virus in 24 Hours
Kerry Grens | Feb 25, 2018
One dose of the medication, called Xofluza, cripples influenza by interfering with an enzyme critical for viral replication.  
Antiviral Immunotherapy Comes of Age
Antiviral Immunotherapy Comes of Age
Lucas Laursen | Dec 4, 2017
T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections.